Keynote Addresses

Keynote Addresses

Saved in:

Bibliographic Details
Main Author:	Marie Bilodeau
Format:	Article
Language:	English
Published:	Humber Press 2019-12-01
Series:	Journal of Innovation in Polytechnic Education
Online Access:	https://jipe.ca/index.php/jipe/article/view/71
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Keynotes
Published: (2025-05-01)

Training and research: Art Therapy for social justice. A keynote address
by: Lireko Qhobela
Published: (2024-07-01)

Keynote Article
by: Zervas Efthimios
Published: (2024-01-01)

Keynote Closing Address for EAC12: The Worldwide State of Experimental Archaeology and the Agenda for the Future
by: Linda Hurcombe, et al.
Published: (2021-08-01)

Keynote: The science that Versailles forgot
by: Colin Jones
Published: (2025-05-01)

Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies
by: Richard S. Finn, et al.
Published: (2025-06-01)

On Writing for Young People Conference 2023, Keynote Speech
by: Julia Green
Published: (2023-12-01)

Multiple Criteria Decision Aiding by Constructive Preference Learning (Keynote Lecture — Extended Abstract)
by: Roman Słowiński
Published: (2023-09-01)

Immunotherapy and Interventional Radiology (IR): Time to Change the Paradigm—Keynote Lecture PAIRS 2021
by: Thierry de Baère
Published: (2021-01-01)

The 7 Habits of Highly Effective IRs: Keynote Lecture at PAIRS2023 Annual Meeting
by: Mohammad Arabi
Published: (2023-01-01)

Educating Well: A Keynote on a Future Paradigm for Applied Arts and Health in Education
by: Ross W. Prior, et al.
Published: (2021-01-01)

The Future of IR: Ascending! Keynote Lecture at the Pairs Annual Scientific Meeting 2017, Dubai, UAE
by: Barry T Katzen
Published: (2017-07-01)

Real world treatment patterns for recurrent and metastatic head and neck cancer in the post-KEYNOTE 048 era
by: Daniel Y. Lee, et al.
Published: (2025-05-01)

PAIRS 2018 Keynote Lecture: The Next Decade in Interventional Radiology: Do We Need More Disruptive Innovation or Better Integration?
by: John A. Kaufman
Published: (2018-07-01)

Keynote PAIRS2024: The Diamond Jubilee of Interventional Radiology, Reflection on the Era of Modernizing Medicine: Our Wins, Losses, and Future Opportunities…
by: Mo Hamady
Published: (2024-07-01)

Reform and responsibility — the climate of history in times of transformation<subtitle>Aalborg Nordic History Congress, Keynote 17 August 2017</subtitle>
by: Sverker Sörlin
Published: (2018-03-01)

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045
by: Anke Richters, et al.
Published: (2025-01-01)

Phenomenon of Demikhov. In the Vishnevsky Institute of Surgery (1947–1955): Scientifi c session at the Institute of Surgery (keynote presentations of B.V. Ognev and V.P. Demikhov)
by: S. P. Glyantsev
Published: (2016-02-01)

Understanding and treating HPV-associated oropharyngeal carcinoma: insights from a MedNewsWeek Keynote lecture by Dr Theodoros N. Teknos and literature review
by: Viviana Cortiana, et al.
Published: (2025-02-01)

Foreword
by: Marie Bilodeau
Published: (2019-12-01)

Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma
by: Emanuel Bührer, et al.
Published: (2025-01-01)

Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.
by: Graham Cohen, et al.
Published: (2024-01-01)

Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
by: Dirk Schadendorf, et al.
Published: (2024-03-01)

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone as the first line treatment for advanced biliary tract cancer: a pooled analysis of KEYNOTE-966 and TOPAZ-1 trails
by: Jiashou Wang, et al.
Published: (2025-06-01)

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study
by: Rebecca Dent, et al.
Published: (2025-03-01)

Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma
by: Oliver John Kennedy, et al.
Published: (2025-01-01)

Addressability
by: Baki Cakiki, et al.
Published: (2025-06-01)

Address to the readers
by: V. E. Sinitsyn
Published: (2019-12-01)

Opening Address
by: Jatmiko Yoga Dwi
Published: (2025-01-01)

Graduation Address
by: Ivan Snook
Published: (2005-05-01)

Presidential Address
by: Rustom J. Maneksha
Published: (1971-12-01)

Opening Address
by: Nwulu N., et al.
Published: (2025-01-01)

Opening Address
by: Bode Florin
Published: (2025-01-01)

Opening Address
by: Hartono, et al.
Published: (2025-01-01)

Change of Address
Published: (1899-01-01)

Concluding Address
by: Franco Giovannelli
Published: (2014-12-01)

Opening address
by: Nazir Novizar
Published: (2025-01-01)

Opening address
by: Gaur Ji Shri Manu Bhaskar, et al.
Published: (2024-01-01)

Address to the readers
by: O. M. Drapkina
Published: (2025-05-01)

Address to the readers
by: O. M. Drapkina
Published: (2023-04-01)